Devous M D, Trivedi M H, Rush A J
Nuclear Medicine Center and Department of Radiology, University of Texas Southwestern Medical Center, Dallas, Texas 75235-9061, USA.
J Nucl Med. 2001 Apr;42(4):535-42.
Functional brain imaging is a powerful tool for examining the central nervous system (CNS) response to pharmacologic challenges. Amphetamine is of interest both because of its role as a stimulant of the dopaminergic system and because of its use to alter mood in mood-disordered patients, particularly in patients suffering from depression. In this study, we report the effects of oral D-amphetamine relative to placebo on regional cerebral blood flow (rCBF) measured by SPECT in healthy volunteers to characterize the normal CNS response to this primarily dopaminergic stimulant.
SPECT was used to assess changes in rCBF induced by amphetamine in 16 healthy volunteers. Subjects received placebo and then 0.4 mg/kg oral amphetamine in a fixed-order single-blind design and were imaged on a triple-head tomograph. Another six healthy volunteers received placebo at both times to assess normal rCBF variability. rCBF changes were assessed with a three-dimensional voxel-based analysis integrated into an automated coregistration system. Data were automatically normalized to whole-brain counts and coregistered. Resultant rCBF changes were evaluated parametrically through the formation of an image whose voxel values were based on the paired t statistic.
Amphetamine increased rCBF in two mesial prefrontal zones (Brodmann's areas 8 and 10), inferior orbital frontal lobe (area 11), brain stem (ventral tegmentum), anteromesial temporal lobe (amygdala), and anterior thalamus. Amphetamine decreased rCBF to motor cortex, visual cortex, fusiform gyrus, posterolateral temporal lobe, and right lateral temporal lobe.
Our data suggest that amphetamine induces focal increases and decreases in rCBF in healthy volunteers in areas primarily innervated by dopamine pathways and in areas with secondary (primarily limbic) affiliations. These data are consistent with glucose metabolic data from autoradiographic studies in animals, in which the largest increases are seen in brain stem, followed by striatum, thalamus, and frontal and sensory cortices. Frontopolar and temporal increases observed in our study appear to be unique to humans.
功能性脑成像技术是一种用于检测中枢神经系统(CNS)对药物刺激反应的强大工具。苯丙胺因其作为多巴胺能系统兴奋剂的作用以及用于改变情绪障碍患者尤其是抑郁症患者的情绪而备受关注。在本研究中,我们报告了口服D - 苯丙胺相对于安慰剂对健康志愿者通过单光子发射计算机断层扫描(SPECT)测量的局部脑血流量(rCBF)的影响,以表征正常CNS对这种主要为多巴胺能兴奋剂的反应。
SPECT用于评估16名健康志愿者中苯丙胺诱导的rCBF变化。受试者在固定顺序的单盲设计中先接受安慰剂,然后口服0.4mg/kg苯丙胺,并在三头断层扫描仪上进行成像。另外6名健康志愿者在两次实验中均接受安慰剂,以评估正常rCBF的变异性。rCBF变化通过集成到自动配准系统中的基于三维体素的分析进行评估。数据自动归一化为全脑计数并进行配准。通过形成一个体素值基于配对t统计量的图像,对所得的rCBF变化进行参数评估。
苯丙胺使两个内侧前额叶区域(布罗德曼区8和10)、眶额下回(区域11)、脑干(腹侧被盖区)、颞叶内侧前部(杏仁核)和丘脑前部的rCBF增加。苯丙胺使运动皮层、视觉皮层、梭状回、颞叶后外侧和右侧颞叶的rCBF减少。
我们的数据表明,苯丙胺在健康志愿者中诱导多巴胺通路主要支配区域以及具有次级(主要是边缘系统)联系的区域的rCBF局部增加和减少。这些数据与动物放射自显影研究中的葡萄糖代谢数据一致,在动物研究中,脑干中增加最大,其次是纹状体、丘脑以及额叶和感觉皮层。我们研究中观察到的额极和颞叶增加似乎是人类特有的。